ORIGINATORS
Originators are developed after many years of laboratory and clinical research and they are subject to strict regulations that ensure their quality, safety and effectiveness.
READ MORE
| TRADE NAME |
ACTIVE INGREDIENT |
THERAPEUTIC CLASSIFICATION |
| Teysuno |
Tegafur, Gimeracil, Oteracil |
Antineoplastic drug |
The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).
GENERICS
Providing safe generics gives patients who would not be able to buy the originator, access to effective treatment, while it saves a great amount of money for the national health system and releases the resources for more expensive treatments.
READ MORE
| TRADE NAME |
ACTIVE INGREDIENT |
THERAPEUTIC CLASSIFICATION |
| Londer |
Anastrozole |
Endocrine treatment |
| Gemcipen |
Gemcitabine Hydrochloride |
Antineoplastic drug |
| Letropen |
Letrozole |
Endocrine treatment |
| Ridoca |
Temozolomide |
Antineoplastic drug |
| Imatinib / Aenorasis |
Imatinib |
Oncology, Haematology |
| Voriconazole / Aenorasis |
Voriconazole |
|
The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).
BIOSIMILARS
Introducing Biosimilars in the international pharmaceutical market improves patients' access to effective treatments, it allows the medical community to provide cost-effective choices and it reduces significantly the total cost of treatment and of the total pharmaceutical expenditure.
READ MORE
| TRADE NAME |
ACTIVE INGREDIENT |
THERAPEUTIC CLASSIFICATION |
| Retacrit |
Epoetin Zeta |
Drug for Aneamia |
| Nivestim |
Filgrastim |
Immunostimulative agent |
The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).
